Yan, Xiaohong
12Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California.
2 papers on CoChatORCID 0000-0002-1945-0453
Most cited papers
- Verified
Adagrasib in Advanced Solid Tumors Harboring a KRAS G12C Mutation
Bekaii-Saab, T. S., Yaeger, R., Spira, A. I., Pelster, M. S., Sabari, J. K., Hafez, N., Barve, M., Velastegui, K., Yan, X., Shetty, A., et al. (2023) · Journal of Clinical Oncology
Protein Kinase Regulation and GTPase SignalingLung Cancer Treatments and Mutations
Cited by 313
- Verified
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer
Yaeger, R., Uboha, N. V., Pelster, M. S., Bekaii-Saab, T. S., Barve, M., Saltzman, J., Sabari, J. K., Peguero, J. A., Paulson, A. S., Jänne, P. A., et al. (2024) · Cancer Discovery
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 139
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free